The Dutch MOCCAS study suggests that noninvasive stool-based surveillance using FIT or multitarget DNA tests could match colonoscopy in reducing…
Browsing: Clinical Updates
The October issue of The American Journal of Gastroenterology brings cutting-edge research on several crucial topics, including insurance-related challenges in…
Delays in cancer registry reporting may have skewed the findings of the NordICC trial, which evaluated the long-term impact of…
A new study presented at the 2024 United European Gastroenterology (UEG) Week reveals that computer-aided diagnosis (CADx) systems perform differently…
Denmark’s Zealand Pharma and German partner Boehringer Ingelheim have received Breakthrough Therapy designation from the U.S. Food and Drug Administration…
New research offers hope for improving the lives of those living with inflammatory bowel disease (IBD), including ulcerative colitis and…
Researchers have developed a promising microbiome-based diagnostic test for inflammatory bowel disease (IBD), leveraging metagenomic data from nearly 6,000 fecal…
New research presented at DDW 2024 reveals that combining cognitive behavioral therapy (CBT) with mindfulness techniques significantly improves the mental…
The FDA has approved ustekinumab-aauz (Otulfi), a biosimilar to Stelara by Johnson & Johnson, for treating conditions like Crohn’s disease,…
A new study suggests that patients taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound may have inadequate bowel or…